Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
A molecular decoy that neutralizes the SARS-CoV-2 virus by preventing it from latching onto cells protected mice against COVID-19.
People with greater immune resilience may be at lower risk for severe COVID-19, AIDS and recurrent skin cancer, NIAID grantees find.
People 65 and older and immunocompromised people can get a second bivalent booster; most unvaccinated people now need only one initial shot.
Herpes, HIV, Epstein-Barr and other viruses hang around, causing potential long-term health woes. Should long COVID surprise us?
Monoclonal antibodies used to prevent COVID-19 in immunocompromised people aren’t active against new virus variants.
Older people, immunocompromised people and those with underlying health conditions can benefit most from additional shots.
The monoclonal antibody combo is used as pre-exposure prophylaxis for immunocompromised people who may not respond to COVID-19 vaccines.
Safety tips for the evolving pandemic. Plus: Which groups—such as those with cancer or HIV—are at higher risk for COVID-19 complications?
NCCN’s new recommendations for COVID-19 vaccines include children with cancer as well as their caregivers.
The update aims to help the public better protect themselves and understand their risk.
Extra vaccine doses, monoclonal antibodies and antivirals can help prevent severe illness.
CoVac-1 induced T-cell responses in about 90% of immunocompromised people with impaired B-cell function.
While vaccination typically provides robust protection against severe disease, they’re less effective for immunocompromised people.
Immunocompromised people ages 12 and older are also eligible for an additional shot.
Protecting the immunocompromised is not only a matter of health equity, it’s critical to ending the pandemic.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.